CA3148785A1 - Melanocyte-regulating peptides - Google Patents
Melanocyte-regulating peptides Download PDFInfo
- Publication number
- CA3148785A1 CA3148785A1 CA3148785A CA3148785A CA3148785A1 CA 3148785 A1 CA3148785 A1 CA 3148785A1 CA 3148785 A CA3148785 A CA 3148785A CA 3148785 A CA3148785 A CA 3148785A CA 3148785 A1 CA3148785 A1 CA 3148785A1
- Authority
- CA
- Canada
- Prior art keywords
- cio
- alkyl
- group
- peptide
- arg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19382674.0 | 2019-08-02 | ||
| EP19382674 | 2019-08-02 | ||
| PCT/EP2020/071629 WO2021023646A1 (en) | 2019-08-02 | 2020-07-31 | Melanocyte-regulating peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3148785A1 true CA3148785A1 (en) | 2021-02-11 |
Family
ID=67658460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3148785A Pending CA3148785A1 (en) | 2019-08-02 | 2020-07-31 | Melanocyte-regulating peptides |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US12492225B2 (https=) |
| EP (1) | EP4007563A1 (https=) |
| JP (2) | JP2022542512A (https=) |
| KR (1) | KR20220041094A (https=) |
| CN (1) | CN114245800A (https=) |
| AR (1) | AR119529A1 (https=) |
| AU (1) | AU2020325636A1 (https=) |
| BR (1) | BR112022001729A2 (https=) |
| CA (1) | CA3148785A1 (https=) |
| CL (1) | CL2022000208A1 (https=) |
| IL (1) | IL290019B2 (https=) |
| MX (1) | MX2022001114A (https=) |
| TW (1) | TWI889695B (https=) |
| WO (1) | WO2021023646A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116120401B (zh) * | 2023-03-22 | 2025-09-30 | 中国科学院昆明动物研究所 | 一种抗黑色素瘤活性多肽kw13、药物及应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0201863D0 (en) * | 2002-06-18 | 2002-06-18 | Cepep Ab | Cell penetrating peptides |
| US20060014712A1 (en) * | 2004-05-30 | 2006-01-19 | Cemines, Inc. | Controlled delivery of therapeutic compounds |
| CN106011233A (zh) * | 2010-08-13 | 2016-10-12 | 莫尔豪斯医学院 | 中风的生物标记 |
| DK3430031T3 (da) * | 2016-03-15 | 2022-01-17 | Idp Discovery Pharma S L | Peptider med anti-kræftaktivitet |
| AU2018311130A1 (en) * | 2017-08-02 | 2020-02-20 | Idp Discovery Pharma, S.L. | Anticancer peptides |
| US20210231663A1 (en) * | 2017-12-12 | 2021-07-29 | Oncimmune Germany Gmbh | Melanoma checkpoint inhibitor detection and treatment |
-
2020
- 2020-07-30 AR ARP200102140A patent/AR119529A1/es unknown
- 2020-07-30 TW TW109125814A patent/TWI889695B/zh active
- 2020-07-31 KR KR1020227002877A patent/KR20220041094A/ko active Pending
- 2020-07-31 JP JP2022506027A patent/JP2022542512A/ja active Pending
- 2020-07-31 AU AU2020325636A patent/AU2020325636A1/en active Pending
- 2020-07-31 MX MX2022001114A patent/MX2022001114A/es unknown
- 2020-07-31 IL IL290019A patent/IL290019B2/en unknown
- 2020-07-31 WO PCT/EP2020/071629 patent/WO2021023646A1/en not_active Ceased
- 2020-07-31 EP EP20747418.0A patent/EP4007563A1/en active Pending
- 2020-07-31 CN CN202080056109.0A patent/CN114245800A/zh active Pending
- 2020-07-31 US US17/632,463 patent/US12492225B2/en active Active
- 2020-07-31 CA CA3148785A patent/CA3148785A1/en active Pending
- 2020-07-31 BR BR112022001729A patent/BR112022001729A2/pt unknown
-
2022
- 2022-01-26 CL CL2022000208A patent/CL2022000208A1/es unknown
-
2025
- 2025-05-20 JP JP2025083931A patent/JP2025131623A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CL2022000208A1 (es) | 2022-09-09 |
| IL290019A (en) | 2022-03-01 |
| TW202120117A (zh) | 2021-06-01 |
| TWI889695B (zh) | 2025-07-11 |
| AR119529A1 (es) | 2021-12-22 |
| JP2025131623A (ja) | 2025-09-09 |
| US20230312649A1 (en) | 2023-10-05 |
| KR20220041094A (ko) | 2022-03-31 |
| AU2020325636A1 (en) | 2022-02-10 |
| IL290019B1 (en) | 2025-09-01 |
| JP2022542512A (ja) | 2022-10-04 |
| BR112022001729A2 (pt) | 2022-04-12 |
| MX2022001114A (es) | 2022-05-03 |
| WO2021023646A1 (en) | 2021-02-11 |
| US12492225B2 (en) | 2025-12-09 |
| IL290019B2 (en) | 2026-01-01 |
| CN114245800A (zh) | 2022-03-25 |
| EP4007563A1 (en) | 2022-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210008159A1 (en) | Peptides with anti-cancer activity | |
| JP2025131623A (ja) | メラノサイト調節ペプチド | |
| CA3071642A1 (en) | Anticancer peptides | |
| AU2018311129B2 (en) | Anticancer peptides | |
| RU2835064C2 (ru) | Меланоцит-регулирующие пептиды | |
| JP7361689B2 (ja) | 抗がんペプチド | |
| CA3017424C (en) | Peptides with anti-cancer activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240726 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20240726 Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20240726 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20240911 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20240911 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20241007 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20241024 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20241024 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20241024 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20250118 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250319 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20250724 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD Year of fee payment: 5 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250725 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250725 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20260316 |